Literature DB >> 18223212

Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma.

Jessica Boult1, Keith Roberts, Matthew J Brookes, Sharon Hughes, Jonathan P Bury, Simon S Cross, Gregory J Anderson, Robert Spychal, Tariq Iqbal, Chris Tselepis.   

Abstract

PURPOSE: There is growing evidence that iron is important in esophageal adenocarcinoma, a cancer whose incidence is rising faster than any other in the Western world. However, how iron mediates carcinogenesis at the molecular level remains unclear. In this study, we investigated the expression of iron transport proteins involved in cellular iron import, export, and storage in the premalignant lesion Barrett's metaplasia and esophageal adenocarcinoma. EXPERIMENTAL
DESIGN: Perls' staining was used to examine iron deposition in tissue. mRNA expression in samples of Barrett's metaplasia matched with esophageal adenocarcinoma and samples of Barrett's metaplasia without evidence of adenocarcinoma were examined by real-time PCR. Semiquantitative immunohistochemistry was used to examine cellular localization and protein levels. The effect of iron loading on cellular proliferation and iron transporter expression was determined in esophageal cell lines OE33 and SEG-1 using a bromodeoxyuridine assay and real-time PCR, respectively.
RESULTS: In the progression of Barrett's metaplasia to adenocarcinoma, there was overexpression of divalent metal transporter 1 (DMT1), transferrin receptor 1, duodenal cytochrome b, ferroportin, and H-ferritin, and these changes were associated with increased iron deposition. Overexpression of DMT1 was further associated with metastatic adenocarcinoma. Iron loading OE33 and SEG-1 cells caused increased cellular proliferation, which was associated with increased H-ferritin and decreased transferrin receptor 1 and DMT1 expression.
CONCLUSIONS: Progression to adenocarcinoma is associated with increased expression of iron import proteins. These events culminate in increased intracellular iron and cellular proliferation. This may represent a novel mechanism of esophageal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223212     DOI: 10.1158/1078-0432.CCR-07-1054

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  42 in total

Review 1.  Circadian rhythm disruption in cancer biology.

Authors:  Christos Savvidis; Michael Koutsilieris
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

2.  Ferroportin and iron regulation in breast cancer progression and prognosis.

Authors:  Zandra K Pinnix; Lance D Miller; Wei Wang; Ralph D'Agostino; Tim Kute; Mark C Willingham; Heather Hatcher; Lia Tesfay; Guangchao Sui; Xiumin Di; Suzy V Torti; Frank M Torti
Journal:  Sci Transl Med       Date:  2010-08-04       Impact factor: 17.956

3.  Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Xueying Liang; Ruth M Pfeiffer; William Wheeler; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

4.  Iron chelation: a potential therapeutic strategy in oesophageal cancer.

Authors:  B D Keeler; M J Brookes
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

5.  A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy.

Authors:  S J Ford; M R Bedford; W Pang; A Wood; T Iqbal; C Tselepis; O Tucker
Journal:  Ann R Coll Surg Engl       Date:  2014-05       Impact factor: 1.891

6.  Lubiprostone protects esophageal mucosa from acid injury in porcine esophagus.

Authors:  Leandi Krüger; Tiffany A Pridgen; Ellie R Taylor; Katherine S Garman; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-18       Impact factor: 4.052

7.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 8.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

9.  Barrett's esophagus: where do we stand?

Authors:  Majid A Al Madi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 10.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.